Oneview Healthcare PLC to Open New U.S. HQ Following Significant Wins Three Proof of Concept Contracts Signed With Three Midwest Healthcare Systems; New North American Headquarters to Be Established In Chicago in June 2016

CHICAGO, IL / ACCESSWIRE / May 27, 2016 / Ireland’s Oneview Healthcare (ASX:ONE), the Australian listed Irish healthcare company, today announced that it will establish a new U.S. headquarters in Chicago, IL, to service its rapidly growing U.S. client base. The news comes as Oneview signs three separate new proof of concept (POC) contracts with high-profile health systems in the Midwest of the United States.

The contracts, which typically run for 90 days, include the deployment and integration of Oneview’s innovative patient experience platform in specific units of three different hospitals (typically across 25-40 beds) and integration with each hospital’s existing IT infrastructure. Extensive live testing of the Oneview Platform will be undertaken in the hospital environment throughout the period against key performance indicators.

This follows a key win earlier this week when Oneview signed a multi-year contract with NYU Langone Medical Center, one of the premier academic medical institutions in the U.S., operating five hospitals, clinics and medical centers across New York. The contract will see the deployment of Oneview’s innovative software at NYU’s 374 bed state-of-the-art facility in New York, and extends Oneview’s reach from the East to the West Coast where it is currently operational in three San Francisco facilities.

Mark McCloskey, Founder and President of Oneview commented: “These are extremely exciting developments for us as a company. We are delighted to be continuing to partner with some of the most innovative healthcare organizations in the world and look forward to working with them to demonstrate the power of the Oneview Platform. We continue to make significant inroads into the key U.S. healthcare market and the opening of our North American headquarters in Chicago demonstrates our commitment to these clients and our rapidly growing team of professionals in the United States.”

Oneview continues to scale and execute the business plan after successfully listing on the Australian Stock Exchange in March 2016. The IPO raised A$62.4 million for Oneview and currently has a fully diluted market capitalization of approximately A$240 million as at 20th May 2016. The new headquarters will employ up to 30 staff and act as the business hub for Oneview’s rapidly scaling U.S. platform.

Enquiries:

About Oneview Healthcare

Oneview Healthcare’s innovative Patient Engagement and Clinical Workflow Solution seamlessly integrates a hospital’s IT system onto one high performance technology platform. It provides pointof-care access to those systems across all end user devices, including bedside terminal, TV, tablet and smart phone.

Through its services and applications, which include treatment education for patients, entertainment and interactive patient care services, Oneview enables hospitals to optimize patient engagement, clinical outcomes and workflow efficiencies – revolutionizing the patient experience.

This capability enables hospitals achieve quantifiable improvements across key performance areas resulting in; improved HCAHPS ratings, reduced re-admissions, meaningful use achievement, improved clinical outcomes and greater patient satisfaction.

The Oneview Healthcare Solution is now recognized globally as being one of the most innovative patient engagement products in the healthcare market. Testimony to this is the company’s partnerships with industry leaders worldwide including Microsoft and Lenovo and its growing list of customers in the USA, Australia and the Middle East.

Oneview commenced operations in 2008 and has offices in Dublin, Pittsburgh, Atlanta, Dubai, Sydney and Melbourne. Oneview Healthcare is headquartered in Dublin, the location for all its R&D and software development.

Investors:

James Fitter
Chief Executive Officer Oneview Healthcare
jfitter@oneviewhealthcare.com

Media:

Ireland:
Maria Cryan, Hume Brophy:
oneview@humebrophy.com
Ph: +353 (0) 1 662 4712

Australia:
Greg Baxter, Newgate Communications:
Greg.Baxter@newgatecomms.com.au
Mobile +61 419 461 368

SOURCE: Oneview Healthcare

ReleaseID: 440484

NEW YORK, NY / ACCESSWIRE / May 27, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of DeVry Education Group, Inc. (“DeVry” or the “Company”) (NYSE: DV) between February 4, 2011 and January 27, 2016.

You are hereby notified that a securities class action has commenced in the USDC for the Northern District of Illinois. If you purchased or otherwise acquired DeVry securities between February 4, 2011 and January 27, 2016, your rights may be affected by this action. To get more information go to: http://www.zlk.com/pslra/devry-education-group.

The complaint alleges that, throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose, among other things, that: (i) DeVry University engaged in a multi-year deceptive marketing and advertising campaign; (ii) DeVry University overstated its students’ ability to find employment after graduation (iii) DeVry University overstated the potential income its students could earn after graduation; (iv) and as a result, DeVry overstated its growth, revenue, and earnings potential by concealing the true employment prospects of DeVry University graduates to investors and potential students.

Shares of DeVry have fallen from a close of $53.47 per share on February 3, 2011, the day before the class period, to a close of just $20.09 on January 27, 2016.

If you suffered a loss in DeVry you have until July 12, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://www.zlk.com/pslra/devry-education-group.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street – 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 440486

Peoples Company, a Leader in Land Transactions, Management, Appraisals, And Auctions, Is Marrying the World’s Oldest Commodity with the Newest Technology

CLIVE, IA / ACCESSWIRE / May 27, 2016 / Peoples Company is launching a mobile auction bidding app to make it easier for bidders to “land” the property they want from the convenience of their smartphone or tablet. That means bidders can bid on property they’re interested in even if they’re hundreds or even thousands of miles away. Users can now download the People’s Company mobile bidding app, powered by BidWrangler, from the Apple App Store or the Google Play Store.

The Peoples Company mobile bidding app is an innovative solution for buyers who may be unable to attend the live auction. The app is interactive, so they can follow the auction in real time with instantaneous updates as the auction is unfolding. All of Peoples Company’s land auctions will be included on the app, but some of those involve only live bidding. The app also helps users plan their schedule by sending notifications, updates, and reminders about upcoming auctions.

“The app offers extraordinary convenience for many of our clients as they’re spread across the country. You can live-bid on a farm in Iowa with the touch of a button on your smartphone from virtually anywhere. That’s powerful,” said Peoples Company President Steve Bruere. “It’s a competitive business, and we’re committed to being industry leaders through innovative technology and market knowledge. This, coupled with our ‘boots on the ground’ approach to marketing land, allows us to be a resource for our clients despite their physical location.”

The capabilities of this app ultimately broadens the buyer pool for any given auction as buyers no longer need to be present on auction day. Bruere points out Peoples Company sold 572.22 acres in Appanoose County, Iowa to a Florida-based buyer via the new mobile app in early April.

Download the app today to register for the upcoming online auction of 15 diverse properties owned by the Iowa Department of Transportation spread throughout seven Iowa counties.

Visit PeoplesCompany.com to see all their land listings and follow them on Twitter, Facebook, and LinkedIn to stay up-to-date on their latest auctions and listings, statewide auction results, and other industry news.

About Peoples Company

Peoples Company is a leading agricultural real estate brokerage and land auction company specializing in land management, land appraisal, and land investing services–offered in nine Midwest states. Based in Clive, Iowa, the company’s 70-person team has established key relationships with major institutional investors in land investment space. The cornerstone of Peoples Company’s aggressive marketing efforts is the annual Land Investment Expos, attracting more than 600 people in the heart of ag-country. Peoples Company is licensed to sell real estate in Iowa, Missouri, Illinois, Minnesota, Nebraska, Montana, North Dakota, and South Dakota. For more information, visit www.PeoplesCompany.com or call (800) 855-5263.

Contact:

Steve Bruere, President
steve@peoplescompany.com
(515) 240-7500

SOURCE: Peoples Company

ReleaseID: 440483

VANCOUVER, BC / ACCESSWIRE / May 27, 2016 / CanAlaska Uranium Ltd. (TSXV: CVV) (OTCQB: CVVUF) (FSE: DH7N), is pleased to report that it has optioned two claim groups for diamond exploration to Fjordland Exploration Inc. The two claims comprising 449 hectares and 2045 hectares respectively, were recently staked by the Company, and are located east of the claims CanAlaska optioned to De Beers Canada Inc. in the Northwestern Athabasca Basin, Saskatchewan (see May 18, 2016 news release). The option deals with De Beers and Fjordland collectively comprise eighty-four (84) kimberlite-style targets.

To view an enhanced version of the Athabasca Diamond Projects, please visit:
https://www.accesswire.com/uploads/20807_canalaska1enhanced.jpg

The claims optioned to Fjordland cover anomalous magnetic response targets identified on the Saskatchewan’s Governments airborne magnetics survey completed in 2011. Claim MC00004307 has two prominent magnetic targets. Claim MC00004306 has seven prominent targets.

For a 100% interest in the claims, CanAlaska will receive a cash payment of $50,000 of which $5,000 has been received, and the balance payable on the anniversary date of the Agreement. Fjordland will also issue to CanAlaska 4 million shares on TSX Venture Exchange approval. CanAlaska reserves a 4% Gross Overriding Royalty (“GOR”) for diamonds and a 2% Net Smelter Returns Royalty (“NSR”) for other minerals. Fjordland has the priority right to purchase up to a 2% GOR for $500,000 for each 0.5% GOR thereby reducing CanAlaska’s GOR to 2%. Aggregate work commitments are $100,000 by December 31, 2017; not less than 40% of expenditures shall qualify as allowable assessment work. The terms of the Agreement are subject to approval of the TSX Venture Exchange.

West Carswell and Alberta 100% Owned Diamond Projects

In addition to the properties optioned to De Beers and Fjordland, the Company holds the West Carswell and Alberta Diamond projects. These two large properties, comprising over 200,000 acres, are immediately northeast of a group of kimberlite indicator minerals (KIM) discovered in the McKay -McMurray Field in Alberta. The KIM’s are down-ice from CanAlaska’s properties; their source has yet to be discovered.

To view an enhanced version of the West Carswell and Alberta Projects 2011 Airborne Survey, please visit:
https://www.accesswire.com/uploads/20807_canalaska2enhanced.jpg

West Carswell Project

CanAlaska’s diamond-shaped West Carswell project is located approximately 10 km west of the Cluff Lake uranium mine, and encompasses 6 discrete line magnetic anomalies derived from the 2011 Saskatchewan geological survey.

These six targets exhibit discrete magnetic lows and are characteristic of magnetic features intruding the thick sequence of Athabasca sandstone lying above the southern portion of the Rae craton.

Alberta Diamond Project

CanAlaska holds an additional 184,320 acres (73,728 ha) of mineral claims in neighbouring Alberta where wide-spaced airborne magnetic surveys have been completed. These surveys show circular magnetic anomalies similar to those recognized from the Saskatchewan survey data.

Of special interest are at least two kimberlite style anomalies within the Alberta project in an area where the Saskatchewan and Alberta surveys overlap as shown on figure 2. The confirmation of these two targets and the recognition of anomalous features from the earlier wide-spaced Alberta survey data, indicates that the clusters of kimberlite-style features noted in Saskatchewan may continue into Alberta.

Discussions are underway with parties who may be able to assist the Company to further develop these targets.

For more information about CanAlaska’s Athabasca kimberlite project visit http://www.canalaska.com/s/AthabascaKimberliteProject.asp?ReportID=740492

About CanAlaska Uranium

CanAlaska Uranium Ltd. (TSXV: CVV) (OTCQB: CVVUF) (FSE: DH7N) holds interests in approximately 700,000 hectares (1.7 million acres), one of the largest land positions in Canada’s Athabasca Basin region – the “Saudi Arabia of Uranium.” CanAlaska’s strategic holdings has attracted major international mining companies Cameco, Denison, KORES, KEPCO, and the De Beers Group of Companies, as partners at its core projects. CanAlaska is a project generator and is positioned for discovery success in the world’s richest uranium district. For further information visit www.canalaska.com.

The qualified technical person for this news release is Dr Karl Schimann, P. Geo, VP Exploration, for CanAlaska.

On behalf of the Board of Directors

“Peter Dasler”

Peter Dasler, M.Sc., P.Geo.
President & CEO
CanAlaska Uranium Ltd.

Contacts:

Peter Dasler
President
Tel: +1.604.688.3211 x 138
Email: info@canalaska.com

John Gomez
Corporate Development
Tel: +1.604.484.7118
Email : jgomez@canalaska.com

The TSX-V has not reviewed and does not accept responsibility for the adequacy or accuracy of this release: CUSIP# 13708P 10 2.

SOURCE: CanAlaska Uranium Ltd.

ReleaseID: 440485

The New Website Features Natural Products at Affordable Prices

LOS ANGELES, CA / ACCESSWIRE / May 27, 2016 / DF Weyland LLC is pleased to announce the launch of their new website, KBIHealth.com. As a company spokesperson noted, the quality health and beauty products from DF Weyland LLC feature all natural and proven ingredients.

Even though the DF Weyland LLC website has not been live for that long, it has already caught the attention of reviewers at Morning Health News. In reviewing their product line, the team from Morning Health News noted that DF Weyland is committed to offering top-quality products at low prices.

For example, one of the health and beauty products that is already creating a buzz with customers is Pure Moroccan Argan Oil. The oil, which is naturally derived from the kernels of the Argan tree in North Africa, is typically used to treat a number of skin conditions including flaky and dry skin.

Another DF Weyland product that was favorably reviewed by Morning Health News is the Celleral Age Defying Serum. As a company spokesperson noted, the product is made from clinically proven ingredients that are designed to provide effective skin nourishment while releasing tension on the skin surface.

“Some of the ingredients contained in the serum include Trylagen PCB, Glucare S 2 percent, Gatuline In-tense and Glucare S,” the spokesperson said, adding that the innovative formula used to produce the Celleral serum may also help to minimize the appearance of fine lines.

“It can also enhance the skin’s smoothness, elasticity and plumpness. For a much stronger effect on various signs of aging, the manufacturers recommend bundling the serum with the Celleral Youth Eye Gel.”

As the company spokesperson noted, the Celleral Youth Eye Gel is an under-eye cream that is designed to ward off signs of aging on the delicate skin near the eyes. The product contains a trio of ingredients: Regu-age, DuPont Glypure and Syn-Coll that are blended with Pronalen Fruit Acids. The all-natural gel may also help to reduce eye puffiness, fine lines and “eye bags,” the spokesperson said.

Anybody who would like to learn more about DF Weyland LLC is welcome to visit the newly-launched website at any time; there, they can read more about the company’s line of natural health and beauty products.

About DF Weyland LLC:

DF Weyland LLC specializes in health and beauty products that have natural and proven ingredients. To read more about the different active ingredients contained in their products go to their website at: http://www.kbihealth.com/.

Contact:

Rufus Copeland
admin@rocketfactor.com
(949) 555-2861

SOURCE: DF Weyland LLC

ReleaseID: 440482